Predictions
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.92
03.03.23
03.03.23
€19.79
03.03.24
03.03.24
797.26%
04.03.24
04.03.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€299.80
03.03.23
03.03.23
€339.30
03.03.24
03.03.24
142.83%
04.03.24
04.03.24
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€18.54
24.06.23
24.06.23
€27.00
31.12.25
31.12.25
347.68%
03.03.24
03.03.24
Could be very worthwhile Investment >20% year
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€38.80
02.03.23
02.03.23
€45.28
02.03.24
02.03.24
71.39%
03.03.24
03.03.24
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€23.20
02.03.23
02.03.23
€33.06
02.03.24
02.03.24
69.83%
03.03.24
03.03.24
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€23.20
02.03.23
02.03.23
€30.22
02.03.24
02.03.24
69.83%
03.03.24
03.03.24
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€7.79
19.02.24
19.02.24
€6.00
16.05.26
16.05.26
-69.17%
03.03.24
03.03.24
Could be very worthwhile Investment >20% year
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€40.60
01.03.23
01.03.23
€54.33
01.03.24
01.03.24
63.79%
02.03.24
02.03.24
Nektar Therapeutics
Start price
Target price
Perf. (%)
€1.32
28.02.23
28.02.23
€1.88
28.02.24
28.02.24
-50.72%
29.02.24
29.02.24
Fibrogen Inc.
Start price
Target price
Perf. (%)
€0.88
25.01.24
25.01.24
€1.30
25.01.25
25.01.25
143.18%
19.02.24
19.02.24
Could be very worthwhile Investment >20% year
Cymabay Therapeutics Inc
Start price
Target price
Perf. (%)
€15.70
12.11.23
12.11.23
€20.00
31.03.26
31.03.26
89.81%
17.02.24
17.02.24
Could be very worthwhile Investment >20% year
Atara Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.25
03.02.24
03.02.24
€1.00
03.02.25
03.02.25
-44.24%
17.02.24
17.02.24
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.55
14.12.23
14.12.23
€3.00
14.12.24
14.12.24
128.19%
09.02.24
09.02.24
Kura Oncology Inc
Start price
Target price
Perf. (%)
€17.70
25.01.24
25.01.24
€16.00
31.08.25
31.08.25
9.60%
02.02.24
02.02.24
Could be very worthwhile Investment >20% year
Novavax Inc.
Start price
Target price
Perf. (%)
€11.01
11.01.23
11.01.23
€6.00
11.01.24
11.01.24
-61.64%
12.01.24
12.01.24
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€529.00
18.12.23
18.12.23
€558.00
18.12.24
18.12.24
6.62%
06.01.24
06.01.24
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€239.95
01.04.22
01.04.22
€330.00
18.12.23
18.12.23
41.68%
14.11.23
14.11.23
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€337.60
09.04.23
09.04.23
€362.00
09.10.23
09.10.23
57.73%
09.10.23
09.10.23
Amgen Inc.
Start price
Target price
Perf. (%)
€246.80
19.09.23
19.09.23
€250.00
19.09.24
19.09.24
4.13%
27.09.23
27.09.23
Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating